A health platform focused on prevention, early intervention and addressing health inequalities has raised £1.25m from Praetura Ventures.
SiSU Health will use this funding to expand its team and accelerate the reach of its digital health solutions across the UK and Europe.
The firm supports the early detection of risk factors, such as high blood pressure and obesity, with the aim of encouraging healthier lifestyle changes.
The funding comes from the GMC Life Sciences Fund By Praetura, which comprises Bruntwood SciTech, Greater Manchester Combined Authority and Enterprise Cheshire and Warrington. Investment has also come from NPIF II – Praetura Equity Finance, which is managed by Praetura as part of the Northern Powerhouse Investment Fund II.
Already supporting nearly 20,000 people a month with their health, the business is now using this latest investment to grow its reach across the UK and Europe.
As part of that growth, SiSU Health will be building on its Northern presence and expanding the operations and manufacturing of SiSU Health Stations within Manchester. The business is also currently working with the Department of Business & Trade to source a larger premises.
The company’s Australian business was fully acquired by Wesfarmers in 2024 and remains fully operational under that new ownership.
“We’re building a future where everyone has the tools and confidence to take control of their health – wherever they are,” said Samantha Fay, CEO at SiSU Health.
“This funding allows us to scale our digital platform, extend our reach into new communities, and strengthen our collaborations and integrations across employer, public health and primary care.
“Prevention has to be proactive, accessible and data-informed – and that’s exactly what SiSU Health delivers.”
The news comes at a time when life expectancy is stalling across the UK for the first time and even falling in some areas with significant differences in years of good health according to where you live.
With over one million health checks delivered to date, SiSU Health data shows that over 70% of users of the SiSU Health platform have not had a recent blood pressure check, despite high blood pressure being one of the leading factors for cardiovascular disease and often preventable through earlier interventions.
Building on a significant portfolio of clients such as Aldi, Jaguar Land Rover, The AA, Workday and a range of council and NHS Trust clients, the company has recently played a key role in the delivery of the Department of Health and Social Care funded CVD Workforce Health Check Program and plans to launch a new Public Health proposition to the market later this year.
Sim Singh-Landa, head of the GMC Life Sciences Fund By Praetura, added: “SiSU Health is bringing health into the modern age by helping individuals to take a health test at a time that’s convenient to them without judgement and the costs that can be associated with health checks.
“They are critically providing connected collaboration between the corporate world and public health systems, encouraging self-care and health awareness for individuals with supported follow-up and interventions, which has significant benefits for the NHS and public health.
“This latest co-investment between the GMC Life Sciences Fund By Praetura and NPIF II also shows the power of two well-established regional funders working together to help propel great companies in the region.”